A Simplified Minimal Residual Disease Polymerase Chain Reaction Method at Early Treatment Points Can Stratify Children With Acute Lymphoblastic Leukemia Into Good and Poor Outcome Groups

Haematologica - Italy
doi 10.3324/haematol.2008.003137
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma

American Journal of Pathology
Forensic MedicinePathology
1999English

Low Platelet Counts After Induction Therapy for Childhood Acute Lymphoblastic Leukemia Are Strongly Associated With Poor Early Response to Treatment as Measured by Minimal Residual Disease and Are Prognostic for Treatment Outcome

Haematologica
Hematology
2011English

Uncovering Early, Lineage-Dependent Effects of TPMT Genotype in Adult Acute Lymphoblastic Leukemia by Minimal Residual Disease

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Quantification of Free Total Plasma DNA and Minimal Residual Disease Detection in the Plasma of Children With Acute Lymphoblastic Leukemia

Annals of Hematology
MedicineHematology
2009English

Relationship Between Minimal Residual Disease Measured by Multiparametric Flow Cytometry Prior to Allogeneic Hematopoietic Stem Cell Transplantation and Outcome in Children With Acute Lymphoblastic Leukemia

Haematologica
Hematology
2010English

Immunologic Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia: A Comparative Approach to Molecular Testing

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

HOXA-activated Early T-Cell Progenitor Acute Lymphoblastic Leukemia: Predictor of Poor Outcome?

Haematologica
Hematology
2016English

Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2000English

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy